Abstract:Measles vaccination In Russian Federation was introduced in 1967. It was assumed that the twodose vaccination regime would lead to a decrease in the incidence and elimination of measles. A number of studies have shown that up to 10% of individuals who received two doses of measles vaccine do not develop a specific humoral immunity, or do not maintain it at a protective level. This fact may contribute to gradual accumulation of persons susceptible for measles infection in the population, thus leading to emergence of new viral outbreaks in the future. The aim of this study was to perform dynamic monitoring of the post-vaccination measles immunity. The study involved 149 people. All the examined persons were divided into 2 groups. The group of comparison included persons, aged 19 to 51 years, in whom absence of measles immunity was serologically confirmed (n = 76). This group was twice vaccinated with live measles culture vaccine (NPO “Microgen”, Russia). Determination of IgG to measles virus was carried out 1 month after vaccination and revaccination. The control group consisted of persons with documented evidence of double immunization against measles virus, with laboratory-confirmed measles immunity (n = 73), aged 19 to 53 years. The comparative dynamics of development and contents of antibodies in the comparison-control groups were considered, with respect to the WHO age classification. Basic and postvaccinal dynamic determination of IgG to measles virus in serum was performed by ELISA using the “VectoKor-IgG” test system (Vector-Best, Novosibirsk). When analyzing the results of the study, it was noted that the level of measles immunity group in older persons from control group (over 45 years old) was initially higher, than in younger subjects. Among young people, the titers of specific measles antibodies reached the values of the control group of the corresponding age after the first vaccination, whereas the level of specific measles antibodies in older age group was significantly lower compared to the control group even after revaccination. A month after the first immunization, 4 people did not reach the protective level of anti-measles IgG. However, revaccination allowed them to form anti-measles immunity. In the course of our work, a case of non-response to vaccination was identified. Thus, our study showed a sufficient interindividual variability in humoral immune responses to measles vaccination.

Voltammetric Determination of Measles Virus Antibodies Using a Glassy Carbon Electrode Modified with 2-Propargyltio-6-nitro-7-hydroxy-4H-1,2,4-triazolo-4,7-dihydro[5,1-c]-1,2,4-triazine

Simultaneous Determination of Methotrexate and Calcium Folinate with Electrochemical Method Based on a Poly-Absa/functionalized MWNTs Composite Film Modified Electrode

Quartz crystal microbalance based biosensor for rapid and sensitive detection of maize chlorotic mottle virus

Rapid and sensitive detection of maize chlorotic mottle virus using surface plasmon resonance-based biosensor.

Rapid Detection of Measles Virus Using Reverse Transcriptase/Recombinase Polymerase Amplification Coupled with CRISPR/Cas12a and a Lateral Flow Detection: A Proof-of-Concept Study

Voltammetric Determination of a Potential Antiviral Drug Sodium Salt of 3-Nitro-4-Hydroxy-7-Methylthio-4H-[1,2,4]Triazolo[5,1-c][1,2,4]Triazinide Monohydrate

Voltammetric Determination of 7-Ethylthio-3-Nitro-1,2,4-Triazolo[5,1-c]-1,2,4-Triazin-4-One Dihydrate Sodium Salt as a Potential Antiviral Drug

Electrochemical Immunosensors Based on Screen-Printed Gold and Glassy Carbon Electrodes: Comparison of Performance for Respiratory Syncytial Virus Detection

Selection of DNA aptamer for label-free electrochemical aptasensor for the detection of rubella virus

Voltammetric determination of homovanillic acid and vanillylmandelic acid on a disposable electrochemical measuring cell system with integrated carbon composite film electrodes

Simultaneous Electrochemical Quantification of Favipiravir and Molnupiravir as Antiviral Drugs for the Treatment of COVID-19 by Using a Glassy Carbon Electrode Modified by Pd/Co-Mn-MOF-74

Voltammetric determination of Molnupiravir used in treatment of the COVID-19 at magnetite nanoparticle modified carbon paste electrode

COVID-19 electrochemical immunosensor with Ag-MOF: Rapid and high-selectivity nasal swab testing for effective detection

Non-Enzymatic Voltammetric Sensor for Histamine Determination in Saliva for Point-of-Care Diagnostics

Catalytic Adsorptive Stripping Voltammetric Determination of Germanium Employing the Oxidizing Properties of V(IV)-HEDTA Complex and Bismuth-Modified Carbon-Based Electrodes

Evaluation of the focus reduction neutralization and ELISA tests compared to the plaque reduction neutralization test for the detection of antibodies against measles virus

Electrochemical biosensor for the evaluation of monoclonal antibodies targeting the N protein of SARS-CoV-2 virus

Laboratory monitoring of postvaccination measles immunity

Trace determination and electrochemical behaviors of isoniazid on electrochemical pre-treatment glassy carbon electrode

Copper-decorated poly(3-amino-5-mercapto-1,2,4-triazole)-modified glassy carbon electrode-based electrochemical sensor for the simultaneous determination of L-Dopa and Vanillylmandelic acid—an expeditious tool for monitoring neuroblastoma and hepatocellular carcinoma

Rapid quantitative detection system for measles virus‐neutralizing antibodies using HiBiT‐tagged virus‐like particles